Biocept obtains Japanese patent for its target selector oncogene mutation enrichment and detection platform

  1. Biocept obtains Japanese patent for its target selector oncogene mutation enrichment and detection platform  Seeking Alpha

  2. Biocept shares climb after getting Japanese patent for rare cancer detection technology  Proactive Investors USA & Canada

    3. Full coverage